ArticleFrontiers in microbiology2017
First Molecular Detection of
Article in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 32 citations in OpenAlex.
- Genetic diversity, population structure and haplotype analysis of Babesia gibsoni based on the thrombospondin-related adhesive protein (TRAP) gene.Scientific reports · 2026Article
- Urban surveillance ofFrontiers in veterinary science · 2026Article
- Laboratory Evidence for Transovarial Transmission of Babesia gibsoni by Haemaphysalis longicornis.Transboundary and emerging diseases · 2026Article
- Article
- Description and molecular characterisation of Babesia ailuropodae n. sp., a new piroplasmid species infecting giant pandas.Parasites & vectors · 2024Article
- Epidemiological and phylogenetic investigation of Babesia spp. in dogs of Hainan Province/Island, China.Parasitology research · 2023Article
- Article
- Molecular epidemiological investigation of piroplasms carried by pet cats and dogs in an animal hospital in Guiyang, China.Frontiers in microbiology · 2023Article
- Analysis of genetic diversity and population structure ofFrontiers in veterinary science · 2023Article
- 18S rRNA Gene-Based Piroplasmid PCR: An Assay for Rapid and Precise Molecular Screening of Theileria and Babesia Species in Animals.Acta parasitologica · 2022Article
- Molecular Detection ofAnimals : an open access journal from MDPI · 2022Article
- A novel promising diagnostic candidate selected by screening the transcriptome of Babesia gibsoni (Wuhan isolate) asexual stages in infected beagles.Parasites & vectors · 2022Article
- Establishment and Application of an Indirect Enzyme-Linked Immunosorbent Assay for Measuring GPI-Anchored Protein 52 (P52) Antibodies inAnimals : an open access journal from MDPI · 2022Article
- First detection and molecular identification ofInternational journal for parasitology. Parasites and wildlife · 2022Article
- Molecular evidence of piroplasm infection in companion animals in Hunan Province, China.BMC veterinary research · 2020Article
- Molecular detection and genetic characteristics of Babesia gibsoni in dogs in Shaanxi Province, China.Parasites & vectors · 2020Article
- Molecular evidence of Babesia in pet cats in mainland China.BMC veterinary research · 2019Article
- Evaluation ofFrontiers in veterinary science · 2019Article
- Babesia gibsoni endemic to Wuhan, China: mitochondrial genome sequencing, annotation, and comparison with apicomplexan parasites.Parasitology research · 2019Article
- Detection of Babesia gibsoni in dogs by combining recombinase polymerase amplification (RPA) with lateral flow (LF) dipstick.Parasitology research · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Canine piroplasmosis is a significant disease in dogs caused by
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.